loader

nyse:pfe

LATEST ARTICLES
Pharmaceutical Investing

Pfizer Declares Third-Quarter 2025 Dividend

Pharmaceutical Investing

Pfizer Invites Public to View and Listen to Webcast of August 5 Conference Call with Analysts

Pharmaceutical Investing

Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030

Pharmaceutical Investing

Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer

Pharmaceutical Investing

Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer

Pharmaceutical Investing

Pfizer's BRAFTOVI® Combination Regimen Cuts the Risk of Death in Half for Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer

Pharmaceutical Investing

Hearing Against Pfizer Set For 30 May In Contraceptive 'Depo-Provera' Multidistrict Litigation Overseen By Levin Papantonio

pharmaceutical investing

Astellas and Pfizer's XTANDI Shows Long-Term Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer

pharmaceutical investing

Pfizer Enters into Exclusive Licensing Agreement with 3SBio

pharmaceutical investing

Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance

pharmaceutical investing

Pfizer's Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

pharmaceutical investing

Pfizer Declares Second-Quarter 2025 Dividend

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES